Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Aug 27, 2023; 15(8): 1663-1672
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1663
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1663
Complication | Neoadjuvant radiotherapy crude OR (95%CI) | Crude P value | Neoadjuvant radiotherapy adjusted OR/IRR (95%CI) | Adjusted P value |
Total operative time | 0.15 (0.13, 0.16) | < 0.001a | 1.14 (1.11,1.16)1 | < 0.001a |
Perioperative transfusion | 1.49 (1.32, 1.69) | < 0.001a | 1.58 (1.37, 1.82)2 | < 0.001a |
Superficial SSI | 1.13 (0.93, 1.38) | 0.217 | NP | NP |
Organ space SSI | 0.76 (0.63, 0.91) | 0.004a | 0.80 (0.66, 0.97)3 | 0.020a |
30-d reoperation | 1.03 (0.80, 1.32) | 0.832 | NP | NP |
30-d mortality rate | 0.40 (0.21, 0.75) | 0.005a | NP | NP |
30-d readmission rate | 1.14 (0.98, 1.32) | 0.090 | NP | NP |
Renal failure | 0.74 (0.37, 1.47) | 0.382 | NP | NP |
Total hospital stay | 0.09 (0.06, 0.12) | < 0.001a | 0.99 (0.96, 1.02)4 | 0.640 |
Drain in place on POD 30 | 0.76 (0.61, 0.99) | 0.041a | 0.82 (0.64, 1.06)5 | 0.124 |
Pancreatic fistula | 0.47 (0.38, 0.58) | < 0.001a | 0.50 (0.40, 0.63)5 | < 0.001a |
Delayed gastric emptying | 0.81 (0.69, 0.95) | 0.010a | 0.86 (0.72, 1.01)5 | 0.073 |
- Citation: Aploks K, Kim M, Stroever S, Ostapenko A, Sim YB, Sooriyakumar A, Rahimi-Ardabily A, Seshadri R, Dong XD. Radiation therapy prior to a pancreaticoduodenectomy for adenocarcinoma is associated with longer operative times and higher blood loss. World J Gastrointest Surg 2023; 15(8): 1663-1672
- URL: https://www.wjgnet.com/1948-9366/full/v15/i8/1663.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i8.1663